Intersect ENT
XENT
#6216
Rank
โ‚ฌ0.87 B
Marketcap
25,74ย โ‚ฌ
Share price
0.00%
Change (1 day)
23.59%
Change (1 year)

EPS for Intersect ENT (XENT)

EPS in 2020: -2,02ย โ‚ฌ

According to Intersect ENT's latest financial reports the company's current EPS (TTM) is -2,02ย โ‚ฌ. In 2020 the company made an earnings per share (EPS) of -2,02ย โ‚ฌ a decrease over its 2019 EPS that were of -1,25ย โ‚ฌ.

EPS history for Intersect ENT from 2012 to 2020

Annual EPS

Year EPS Change
2020-2,02ย โ‚ฌ62.04%
2019-1,25ย โ‚ฌ80.26%
2018-0,69ย โ‚ฌ35.71%
2017-0,51ย โ‚ฌ-37.08%
2016-0,81ย โ‚ฌ-12.75%
2015-0,93ย โ‚ฌ-36.65%
2014-1,47ย โ‚ฌ37.61%
2013-1,07ย โ‚ฌ24.93%
2012-0,85ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ocular Therapeutix
OCUL
-1,29ย โ‚ฌ-36.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ICON plc
ICLR
5,33ย โ‚ฌ-363.51%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Anika Therapeutics
ANIK
-0,24ย โ‚ฌ-88.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
2,07ย โ‚ฌ-202.44%๐Ÿ‡บ๐Ÿ‡ธ USA